Company Filing History:
Years Active: 1995-2003
Title: Patricia M Beckmann: Innovator in Biotechnology
Introduction
Patricia M Beckmann is a prominent inventor based in Poulsbo, WA (US). She has made significant contributions to the field of biotechnology, particularly in the development of ligands for flt3 receptors. With a total of 4 patents, her work has the potential to impact various medical treatments.
Latest Patents
One of her latest patents involves the Human FLTS3 ligand. This invention discloses ligands for flt3 receptors that are capable of transducing self-renewal signals to regulate the growth, proliferation, or differentiation of progenitor cells and stem cells. The invention is directed to flt3-L as an isolated protein, including the DNA encoding the flt3-L, host cells transfected with cDNAs encoding flt3-L, and compositions comprising flt3-L. Additionally, it outlines methods of improving gene transfer to a mammal using flt3-L and methods of enhancing transplantations using flt3-L. Flt3-L finds use in treating patients with anemia, AIDS, and various cancers. Another significant patent focuses on antibodies against flt3 ligand, which includes anti-flt3-L antibodies and enzyme-linked immunosorbent assays comprising such antibodies.
Career Highlights
Patricia M Beckmann is associated with Immunex Corporation, where she has been instrumental in advancing research and development in her field. Her innovative work has garnered attention and respect within the biotechnology community.
Collaborations
Some of her notable coworkers include David P Gearing and Stewart D Lyman, who have collaborated with her on various projects.
Conclusion
Patricia M Beckmann's contributions to biotechnology, particularly through her patents related to flt3 ligands, demonstrate her commitment to advancing medical science. Her work continues to pave the way for new treatments and therapies that can benefit patients worldwide.